Advertisement
Articles
Advertisement

Focus on Funding 3/17/06

Thu, 03/16/2006 - 10:49am


GOVERNMENT FUNDING

European Nations Provide $14 Million to TB Alliance
The Global Alliance for TB Drug Development received a total of $14 million from the British, Dutch, and Irish governments for preclinical development, ongoing and new clinical trials, and to speed the development of new drugs to treat tuberculosis (TB).
Full Article

Vermont Genetics Network Funded with $16.5M Grant
The National Center for Research Resources at the National Institutes of Health awarded a $16.5 million grant to the University of Vermont (UVM), Burlington, to fund the Vermont Genetics Network, a scientific collaboration between UVM and five other colleges and universities.
Full Article

RPI Scientist Receives NSF Grant for Protein Research
The National Science Foundation (NSF) awarded Rensselaer Polytechnic Institute (RPI), Troy, N.Y., researcher Angel Garcia, PhD, a five-year, $947,000 grant to continue his study of how proteins function under pressure.
Full Article

PRIVATE FUNDING

Broad Foundation Funds New Stem Cell Institute with $25M
The University of Southern California, Los Angeles, received $25 million from The Broad Foundation to create the Broad Institute for Integrative Biology and Stem Cell Research, which will be the largest stem cell research center in California.
Full Article

Cadence Acquires $60.8M
Cadence Pharmaceuticals Inc., San Diego, raised $60.8 million in equity and debt financing in its second round of financing in less than five months to develop an intravenous formulation of acetaminophen.
Full Article

Insulet Raises $50M
Insulet Corp., Bedford, Mass., which manufactures the OmniPod insulin management system, has raised $50 million in financing to expand capacity for the OmniPod, and to fuel product development and ongoing clinical work.
Full Article

InfaCare Acquires $30M in Series A Financing
InfaCare Pharmaceutical Corp., Plymouth Meeting, Pa., raised $30 million in a Series A financing to further develop Stanate to treat severe neonatal jaundice.
Full Article

Neuromed Raises $25M
Neuromed Pharmaceuticals Inc., Conshohocken, Pa., completed a Series D financing of $25 million in its fourth round of financing to further develop its calcium channel blocking technology.
Full Article

GRANTS AVAILABLE

Insulin Signaling and Receptor Cross-Talk
Agency: National Institutes of Health
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: The funding opportunity invites investigator-initiated grant applications to research crosstalk in insulin responses at molecular, cellular, and physiological levels.
Full Article

Development of Disease Biomarkers
Agency: National Institute of Diabetes and Digestive and Kidney Diseases
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: This grant provides resources to validate candidate biomarkers for human diseases of the liver, kidney, urological tract, digestive and hematologic systems, endocrine and metabolic disorders, diabetes and its complications, and obesity.
Full Article

Advances in Polycystic Kidney Disease
Agency: National Institute of Diabetes and Digestive and Kidney Diseases
Estimated Funding: N/A
Due Date for Applications: Multiple dates, see Web site
Description: This grant seeks applications to pursue basic and applied investigations to determine the etiology and pathogenesis of the autosomal dominant and autosomal recessive forms of polycystic kidney disease.
Full Article

Research on the Cognitive Sequelae of Parkinson's Disease
Agency: National Institutes of Health
Estimated Funding: $50,000
Due Date for Applications: Multiple dates, see Web site
Description: This funding announcement seeks grant applications addressing the neurobiological mechanisms associated with cognitive impairment in Parkinson's disease, the development of clinical interventions and therapeutics, or improved clinical diagnosis or treatment of cognitive impairment in Parkinson’s.
Full Article

Proteomics: Diabetes, Obesity, and Endocrine, Digestive, Kidney, Urologic, and Hematologic Diseases
Agency: National Institutes of Health
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: This funding opportunity seeks projects that identify and quantitate protein expression patterns, post-translational modification of proteins, and protein-protein interactions on cells, tissues, organ systems relevant to metabolic diseases, and diseases of the alimentary tract, pancreas, liver, kidney, bladder, and prostate.
Full Article

Calcium Oxalate Stone Diseases
Agency: National Institute of Diabetes and Digestive and Kidney Diseases
Estimated Funding: N/A
Due Date for Applications: May 02, 2009
Description: This grant seeks to increase research into the genetics and heritability of oxalate regulation and oxalate stone diseases, and solicits pilot and feasibility studies using novel approaches to study the diagnosis, treatment, and prevention of these disorders.
Full Article

Research Grants for Studies of Hepatitis C in the Setting of Renal Disease
Agency: National Institute of Diabetes and Digestive and Kidney Diseases
Estimated Funding: $200,000
Due Date for Applications: Multiple dates, see Web site
Description: This announcement invites investigators to submit research grant applications to pursue basic and clinical investigations concerning the pathogenesis, natural history, therapy, and prevention of hepatitis C in renal disease or transplantation.
Full Article


Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading